Eye Catching Biotech Stock: Pulmatrix, Inc. (NASDAQ: PULM)
Pulmatrix, Inc. (NASDAQ: PULM) ended the last transaction at $0.83, with a change of -0.06%. The daily volume was calculated at 256233 shares. The company has a market worth of $16.29M. It holds an average volume of 159.12K shares. In 52-week session, the stock hit the peak level of -81.90% and touched to lowest level of 36.41%.
Pulmatrix, Inc. (PULM) recently reported the appointment of Rick Batycky, Ph.D., to its Board of Directors.
“Rick brings deep expertise in drug development to the board and we are thrilled to welcome him,” stated Ted Raad, Chief Executive Officer of Pulmatrix. “His broad ranging experience in respiratory therapeutics, including Pulmatrix’s iSPERSE™ dry powder inhalation technology will be invaluable as we consider opportunities to bring new therapeutics to market. We look forward to his planned guidance as we plannedally advance our iSPERSE™ platform.”
Dr. Batycky stated, “I believe that Pulmatrix’s iSPERSE™ platform technology has tremendous potential to improve the standard of care for patients suffering from serious pulmonary disease. I look forward to helping advance their critically important pipeline.”
The Company has 19.57 million shares outstanding and 19.57 million shares were floated in market. The short ratio in the company’s stock is documented at 2.3 and the short float is around of 1.87%. The average true range of the stock is observed at 0.05 and the relative strength index of the stock is recorded at 64.73.
